期刊文献+

两种血液净化方法对维持性血液透析患者血清FGF-23的影响 被引量:9

Two blood purification methods on clearing serum fibroblast growth factor-23 in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨血液透析、血液透析滤过对维持性血液透析患者血清成纤维细胞生长因子23(FGF-23)的清除效果。方法 60例维持性血液透析患者分为两组:血液透析组(HD组,n=30),血液透析滤过组(HDF组,n=30)。记录患者治疗前后血清FGF-23以及血钙(Ca)、血磷(P)、血清甲状旁腺激素(iPTH)等指标,并进行组内和组间统计学比较。结果 HD组血清FGF-23从治疗前(858.8±113.5)pg/ml降至治疗后(834.1±94.52)pg/ml,差异无统计学意义(P=0.2768);HDF组血清FGF-23从治疗前(782.5±105.8)pg/ml降至治疗后(712.0±98.05)pg/ml,差异有统计学意义(P=0.0037)。HDF组治疗后血清FGF-23较同期HD组明显降低(P=0.0067)。结论 HD对血清FGF-23无清除效果,HDF对血清FGF-23有清除作用。血清FGF-23对心血管疾病发生和发展有临床研究意义。 Objective To investigate the different clear effect between hemodialysis and hemodiafiltration on the serum fibroblast growth factor-23(FGF-23) in maintenance hemodialysis patients.Methods Sixty maintenance hemodialysis patients were divided into two groups according to on-going dialysis methods: hemodialysis group(HD group,n=30),hemodiafiltration group(HDF group,n=30).Serum pre-and post-treatment FGF-23,Ca,P,iPTH levels were measured,followed by statistical comparison within and between the groups,studied their correlations.Results The serum FGF-23 levels post-hemodialysis was decreased than pre-hemodialysis from(858.8±113.5)pg/ml to(834.1±94.52)pg/ml,the difference was insignificant(P=0.2768).Hemodiafiltration techniques significantly decreased serum FGF-23 levels from(782.5±105.8)pg/ml to(712.0±98.05)pg/ml(P=0.0037).Secondly,the serum FGF-23 levels in HDF group statistically reduced compared with the HD group(P=0.0067).Conclusions Hemodialysis can not clear serum FGF-23.Hemodiafiltration can clear serum FGF-23 effectively.The serum FGF-23 make important part with cardiovascular diseases proceeding.
出处 《齐齐哈尔医学院学报》 2012年第24期3327-3329,共3页 Journal of Qiqihar Medical University
关键词 成纤维细胞生长因子23 血液透析 血液透析滤过 Fibroblast growth factor-23 Hemodialysis Hemodiafiltration
  • 相关文献

参考文献9

  • 1Gutiérrez OM,Mannstadt M,Isakova T. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis[J].New England Journal of Medicine,2008,(06):584-592.
  • 2Nakanishi S,Kazama J J,Nii-Kono T. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients[J].Kidney International,2005,(03):1171-1178.
  • 3Miyamoto K,Ito M,Tatsumi S. New aspect of renal phosphate reabsorption:the type Ⅱc sodium-dependent phosphate transporter[J].American Journal of Nephrology,2007,(05):503-515.
  • 4Goetz R,Nakada Y,Hu MC. Isolated C-terminal tail of FGF23 alleviates hypophosph-atemia by inhibiting FGF23-FGFR-Klotho complex formation[J].Proceedings of the National Academy of Sciences(USA),2010,(01):407-412.
  • 5Razzaque MS,Lanske B. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis[J].Journal of Endocrinology,2007,(01):1-10.
  • 6Perwad F,Zhang MY,Tenenhouse HS. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro[J].American Journal of Physiology-Renal Physiology,2007,(05):F1577-F1583.
  • 7Tentori F,Blayney MJ,Albert JM. Mortality risk for dialysis patients with different levels of serum calcium,phosphorus,and PTH:the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].American Journal of Kidney Diseases,2008,(03):519-530.doi:10.1053/j.ajkd.2008.03.020.
  • 8Torres PU,Friedlander G,De Vernejoul MC. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients[J].Kidney International,2008,(01):102-107.
  • 9Patrier L,Dupuy AM,Granger Vallée A. FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis[J].Journal of Nephrology,2012.27-30.

同被引文献75

  • 1范炜,朱维平,邵洁,史惠强.长期血透患者甲状旁腺素测定的临床意义[J].东南国防医药,2003,5(3):177-179. 被引量:1
  • 2邵素荣,张建荣.FGF-23在继发性甲状旁腺功能亢进症发病机制中的作用进展[J].中国血液净化,2012,11(7):392-395. 被引量:8
  • 3程永衡.不同血液净化方法对维持性血液透析患者血清β_2-微球蛋白和甲状旁腺激素清除率的探讨[J].中国血液净化,2012,11(8):433-435. 被引量:36
  • 4盂建中,贾凤玉,于颖.体外循环血液净化新技术在急危重症患者中的救治作用[J].生物医学丁程研究,2007,26(1):92-96.
  • 5盂建中.血液净化在灾难医学救助中的应用与发展[J].中困血液净化,2010,9(6):330-332.
  • 6王国琴,徐媛,金秀萍.连续性血液净化联合血液灌流治疗儿童危重症合并急性肾衰的护理[C]//中华护理学会.全同儿科护理学术交流会议论文汇编.桂林:中华护理学会,2012:4.
  • 7施素华,梁萌,许树根.连续性血液净化(CBP)在急危重症患者电解质紊乱及酸碱失衡救治中的护理[C]//中国中西医结合学会肾脏疾病专业委员会.第10届全国中西医结合肾脏病学术会议论文汇编.两安:中国中两医结合学会肾脏疾病专业委员会.2009:2.
  • 8振丽.连续性血液净化治疗的护理进展[J].临床合用药杂志,2012,5(32):178-180.
  • 9徐杰.连续血液净化在危重病领域的应用[c]//中国中西医结合学会急救医学专业委员会.2012中国中西医结合学会急救医学专业委员会学术年会论文集.广东:中国中西医结合学会急救医学专业委员会,2012:3.
  • 10詹建生,陈淑娜,谭永港,等.超滤浓缩回输对肝硬化腹水患者自然杀伤T细胞及RAAS系统的影响[J].现代消化及介入治疗.2012.17:133-137.

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部